Blood test could personalize breast cancer treatment, spare some from extra drugs
NCT ID NCT07214532
Summary
This study is testing a personalized approach for people with intermediate-risk, hormone-positive breast cancer. It uses a special blood test to check for tiny signs of cancer. If the test is positive, patients add a targeted drug (CDK4/6 inhibitor) to their standard hormone therapy; if negative, they continue with hormone therapy and regular blood test monitoring. The goal is to see if this guided approach is as effective at preventing cancer return as giving the extra drug to everyone, while potentially reducing unnecessary treatment and side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.